Gritstone Oncology Inc (GRTS) Event Aug. 04, 2022, 00:00 UTC (66% Neutral) Gritstone bio, Inc. (GRTS) Reports 71% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 12:05 p.m. 🏢 Gritstone Oncology Inc (GRTS) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-17.20M $-58.43M $41.24M +70.57% 📉 Total Assets $278.11M $213.95M $64.15M +29.98% 📈 Total Liabilities $62.02M $50.58M $11.45M +22.63% 📉 Stockholders' Equity $178.82M $-343.50M $522.32M +152.06% 📈 Operating Income/Loss $5.50M $2.00M $3.50M +175.00% 📉 R&D Expense N/A N/A N/A +0.00% ➡️ Earningspersharebasic $-0.23 $-0.68 $0.45 +66.18% 📈 Earningspersharediluted $-0.23 $-0.68 $0.45 +66.18% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Gritstone Oncology Inc (GRTS) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document